Elsevier

Neuroscience Letters

Volume 347, Issue 2, 21 August 2003, Pages 89-92
Neuroscience Letters

Repeated administration of methamphetamine causes hypersensitivity of D2 receptor in rat ventral tegmental area

https://doi.org/10.1016/S0304-3940(03)00673-6Get rights and content

Abstract

To elucidate whether the methamphetamine (MAP)-induced hypersensitivity to dopamine occurs in the ventral tegmental area (VTA), patch clamp studies were performed using brain slice preparations. MAP or physiological saline was administered to 8–10-day-old rats daily for 5 days. On day 5, patch clamp studies were performed on VTA dopamine neurons which were identified by morphological and electrophysiological characteristics. Dopamine (1–100 μM) and talipexole (a dopamine D2 receptor agonist, 1–100 μM) produced a dose-dependent hyperpolarization in these neurons; treatment with SKF 38393 or PD128907 (Dl and D3 receptor agonists, respectively) had no effect. The extent of hyperpolarization was significantly greater in the MAP group compared to the saline controls, suggesting that repeated MAP administration causes a hypersensitivity to dopamine that is D2 receptor-dependent. This hypersensitivity reduces the excitability of VTA dopamine neurons, thus decreasing dopamine release in the nucleus accumbens area. This may compensate for the MAP-induced elevation of dopamine levels and modulate the dopamine-induced signal transduction cascades, leading to reverse tolerance in nucleus accumbens neurons.

Section snippets

Acknowledgements

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, by a Grant-in-Aid from the Ministry of Health and Welfare, Japan and by the Sankyo Foundation of Life Science. This work was carried out with equipment of the Research Facilities for Laboratory Animal Science and Research Center for Molecular Medicine, Hiroshima University School of Medicine.

Cited by (11)

  • Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol

    2021, Pharmacology Biochemistry and Behavior
    Citation Excerpt :

    Considering that the GRK6/ARRB2 system prevents G protein-dependent early signaling and induces AKT/GSK-3 signaling, both the GRK6/ARRB2 system and the AKT/GSK-3 signaling alteration may contribute to a reduction of post-DRD2 signaling in DSS. As a similar concept to DSS, the dopamine hypersensitivity state (DHS) is generally known to be induced by repeated psychostimulant administration (Amano et al., 1996; Amano et al., 2003). Several studies have reported that DHS rats exhibited behavioral supersensitivity to dopamine, similarly to DSS rats (Klawans and Margolin, 1975; Amano et al., 2002; Shuto et al., 2006).

  • Tipepidine activates VTA dopamine neuron via inhibiting dopamine D<inf>2</inf> receptor-mediated inward rectifying K<sup>+</sup> current

    2013, Neuroscience
    Citation Excerpt :

    We adjusted the resting membrane potential to approximately −50 mV with injecting currents. This resting membrane potential is observed in DA neurons in slice preparations including VTA (Amano et al., 2003). In this condition, the application of 10−7 M DA immediately hyperpolarized the cell membrane followed by the reduction of firing rate (Fig. 6A).

  • Eating high-fat chow enhances sensitization to the effects of methamphetamine on locomotion in rats

    2011, European Journal of Pharmacology
    Citation Excerpt :

    Among those dopamine receptors, D1 and D2 receptors are thought to be particularly important in the development of sensitization (Kuribara and Uchihashi, 1993; Shuto et al., 2008). Although the number of dopamine D2 receptors is not changed in animals displaying behavioral sensitization to methamphetamine, there is a significant increase in the high affinity state of dopamine D2 receptors that parallels the development of sensitization (Amano et al., 2003; Seeman et al., 2002). Moreover, eating high-fat chow increases sensitivity to effects of direct-acting agonists that are mediated by dopamine D2 receptors (e.g. Baladi and France, 2009).

View all citing articles on Scopus
View full text